Open: 3:25 PM
BioCardia Stock Price Graph
BioCardia Stock Price Today
BioCardia, Inc. (BCDA) stock declined over -5.86% intraday to trade at $0.6496 a share on NASDAQ. The stock opened with a loss of -43.91% at $0.39 and touched an intraday high of $0.39, falling -5.86% against the last close of $0.69. The BioCardia, Inc. in stock market went to a low of $0.38 during the session.
BioCardia Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BioCardia Stock Price History Chart
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Frequently Asked Questions
What is the current BioCardia, Inc. (BCDA) stock price?
BioCardia, Inc. (NASDAQ: BCDA) stock price is $0.65 in the last trading session. During the trading session, BCDA stock reached the peak price of $0.39 while $0.38 was the lowest point it dropped to. The percentage change in BCDA stock occurred in the recent session was -5.86% while the dollar amount for the price change in BCDA stock was -$0.04.
BCDA's industry and sector of operation?
The NASDAQ listed BCDA is part of Biotechnology industry that operates in the broader Healthcare sector. BioCardia, Inc. , a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases.
Who are the executives of BCDA?
Dr. Peter A. Altman Ph.D.
Chief Executive Officer, Pres & Director
Dr. Sujith Shetty
Chief Medical Officer and Vice President of Clinical & Regulatory
Dr. Ian McNiece Ph.D.
Chief Scientific Officer
Dr. Peter A. Altman Ph.D.
CEO, Pres & Director
How BCDA did perform over past 52-week?
BCDA's closing price is 0.89% higher than its 52-week low of $0.36 where as its distance from 52-week high of $2.92 is -0.20%.
How many employees does BCDA have?
Number of BCDA employees currently stands at N/A. BCDA operates from 320 Soquel Way, Sunnyvale, CA 94085, US.
Link for BCDA official website?
Official Website of BCDA is: https://www.biocardia.com
How do I contact BCDA?
How many shares of BCDA are traded daily?
BCDA stock volume for the day was 448452.00 shares. The average number of BCDA shares traded daily for last 3 months was 2.5 Million.
What is the market cap of BCDA currently?
The market value of BCDA currently stands at $14.7 Million with its latest stock price at $0.65 and N/A of its shares outstanding.